Table 1 —

Basic characterization of type 2 diabetic patients and normal subjects

Type 2 diabetic patients submitted to l-arginine or placebo treatmentPool of type 2 diabetic patientsNormal subjects
Sex (M/F)8/414/1122/18
Age (years)57.8 ± 3.253.8 ± 2.056.3 ± 1.2
Body weight (kg)67.0 ± 4.770.2 ± 2.370.0 ± 1.6
BMI (kg/m2)25.3 ± 0.926.1 ± 0.725.1 ± 0.4
Systolic blood pressure (mmHg)124 ± 3129 ± 2129 ± 2
Diastolic blood pressure (mmHg)70 ± 280 ± 4*74 ± 2
Glycated hemoglobin (%)5.7 ± 0.17.2 ± 0.3*4.9 ± 0.2
Fasting plasma glucose (mmol/l)7.2 ± 0.27.9 ± 0.3*5.6 ± 0.1
  • Data are means ± SEM, unless otherwise indicated.

  • *

    * P < 0.05 vs. type 2 diabetic patients submitted to l-arginine or placebo therapy;

  • P < 0.05 vs. both groups of type 2 diabetic patients.